← 返回前沿论文

肿瘤浸润免疫细胞调控子宫内膜癌的分子机制

英文原题:Molecular mechanism of tumor-infiltrating immune cells regulating endometrial carcinoma.

PubMed 2024/11/05(内容时间) Genes Dis Q1 · IF 14.6(JCR 2025)

研究概要

子宫内膜癌(EC)是一种常见的妇科癌症,其与免疫系统的相互作用在癌症进展中至关重要。

中文摘要

子宫内膜癌(EC)是一种常见的妇科癌症,其与免疫系统的相互作用在癌症进展中至关重要。这篇综合性综述探讨了肿瘤浸润免疫细胞调控EC所涉及的分子机制。本综述讨论了肿瘤微环境中各种免疫细胞类型的组成和功能,包括T细胞、B细胞、巨噬细胞和NK 细胞,并阐明了它们在癌症控制中的具体作用。本文还深入探讨了EC细胞所采用的免疫逃逸策略,特别关注免疫检查点通路及其对肿瘤发展的影响。此外,还详细介绍了在肿瘤微环境中介导免疫反应的信号通路、细胞因子和趋化因子。此外,本文还综述了临床意义和治疗策略,如免疫治疗,并讨论了相关临床试验。另外,本综述讨论了现有知识中的空白,提出了未来研究的潜在方向,并强调了理解这些机制对于改善EC治疗的重要性。本综述对当前知识进行了详尽概述,支持对EC更有效治疗干预的持续探索。

展开英文摘要原文

Endometrial carcinoma (EC) is a prevalent gynecological cancer, and its interaction with the immune system is pivotal in cancer progression. This comprehensive review explores the molecular mechanisms involved in the regulation of EC by tumor-infiltrating immune cells. This review discusses the composition and functions of various immune cell types within the tumor microenvironment, including T cells, B cells, macrophages, and natural killer cells, and elucidates their specific roles in cancer control. It also delves into the immune evasion strategies employed by EC cells, with a specific focus on immune checkpoint pathways and their influence on tumor development. Signaling pathways, cytokines, and chemokines mediating immune responses within the tumor microenvironment are also detailed. Furthermore, clinical implications and therapeutic strategies, such as immunotherapies, are also reviewed, and relevant clinical trials are discussed. Additionally, this review discusses the existing gaps in our knowledge, suggests potential avenues for future research, and emphasizes the significance of understanding these mechanisms for enhanced EC treatment. This review provides an exhaustive overview of the current knowledge, supporting the ongoing quest for more effective therapeutic interventions on EC.

论文信息

作者
Ding S、Hao Y、Qi Y、Wei H、Zhang J、Li H
第一作者单位
Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 117004, China.China
通讯作者单位
Department of Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning 117004, China.China
文献类型
综述
期刊
Genes & diseases2025 May
原文标识
PubMed 40083326 · DOI 10.1016/j.gendis.2024.101442